European rally stalls, ASX up and running
Published 18-NOV-2020 09:48 A.M.
|
2 minute read
Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.
In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.
The below articles were written under our previous business model. We have kept these articles online here for your reference.
Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.
Click Here to View Latest Articles
The S&P/ASX 200 Index added 0.2 per cent to close at 6498.2 points on Tuesday. This was above Monday’s nine-month high to end the session 9.3 per cent below its February record close.
China stocks slipped on Tuesday. Losses in healthcare and technology, media and telecom (TMT) stocks were the drivers off lofty valuation concerns, while more bond defaults hit sentiment.
The CSI300 index fell 0.3% to 4,890.57 points at the end of the morning session, while the Shanghai Composite Index fell 0.2%, to 3,340.32 points.
Falling the most, the CSI300 healthcare index and the CSI TMT industries index slid 2.6% and 1.9%, respectively.
In terms of European markets, Chris Beauchamp, Chief Market Analyst at IG says they have trimmed recent gains, with the FTSE 100 suffering most with a 30 point loss.
“The rally has stalled across Europe, pausing for breath after the huge gains of the past week that have been driven by positive vaccine news.
“Overall the atmosphere is still positive but as the euphoria about possible routes out of the crisis begins to fade the focus will shift, to a degree at least, to the manufacture and distribution of the vaccines.
“Nonetheless, risk appetite appears well-supported from here, seasonality, inflows and sentiment all providing a foundation for further gains into the end of the year.
“The main debate will focus on whether value stocks have truly seen a resurgence, or whether, once again, this unloved sector of the market is just enjoying a brief recovery before investor enthusiasm for tech stocks and other high-growth names returns.
“EasyJet shares have taken the news of its first annual loss quite well, all things considering, and have managed to get over the warning about reduced capacity for Q1 2021 too.
“After a 53% gain for the month so far the stock might be considered vulnerable to some downside via profit-taking, but it looks like investors are prepared to stick this one out for now, hoping perhaps that Q2 and Q3 will see a big recovery as the vaccine news filters through to consumers.”
Big news in Crypto
Bitcoin broke through the $17,000 milestone overnight.
Simon Peters, crypto analyst at eToro, said, "Bitcoin has broken through the critical price milestone of $17,000 and looks set to move higher.
"It is not out of the question for the crypto to hit its all time high of $20,000 this side of Christmas. The last time bitcoin was valued at $20,000 a coin was in December 2017, at the height of the crypto’s last bull run.
"Three years on, the crypto industry has consolidated, matured and is seeing real traction with institutional investors. Investors are using bitcoin as an inflationary hedge to combat the prospect of continued government stimulus.
"Will it be a Merry Christmas for bitcoin holders, we’ll have to wait and see but the signs look promising."
Tickers
Dow: -0.56%
S&P 500: -0.48%
NASDAQ: -0.21%
FTSE 100: -0.87%
DAX: -0.04%
CAC 40: +0.21%
Asia Dow: +0.36%
Nikkei 225: +0.42%
Hang Seng: +0.12%
ASX 200: +0.21%
AUD: 0.73
General Information Only
S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.
Conflicts of Interest Notice
S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.
Publication Notice and Disclaimer
The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.
Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.
This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.
